Atlas Trials

A Study of LY3405105 in Participants With Advanced Cancer

Clinical trial NCT03770494 · TERMINATED

Trial details

NCT number
NCT03770494
Sponsor
Eli Lilly and Company
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2019-01-31
Primary completion
2021-02-04
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.